Beijing Tong Ren Tang Chinese Medicine Company Limited
BJTRF
$0.5645
-$0.7413-56.77%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.32% | 42.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.32% | 42.87% | |||
| Cost of Revenue | 0.32% | 57.16% | |||
| Gross Profit | 0.32% | 36.13% | |||
| SG&A Expenses | 0.32% | 51.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.25% | 131.48% | |||
| Total Operating Expenses | 0.32% | 56.16% | |||
| Operating Income | 0.32% | 22.04% | |||
| Income Before Tax | 0.32% | 22.32% | |||
| Income Tax Expenses | 0.32% | 32.67% | |||
| Earnings from Continuing Operations | 0.32% | 20.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -0.32% | 59.41% | |||
| Net Income | 0.32% | 27.93% | |||
| EBIT | 0.32% | 22.04% | |||
| EBITDA | 0.32% | 21.36% | |||
| EPS Basic | 0.47% | 27.98% | |||
| Normalized Basic EPS | 0.63% | 31.67% | |||
| EPS Diluted | 0.47% | 27.98% | |||
| Normalized Diluted EPS | 0.63% | 31.67% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.00% | |||